Published in Am J Pathol on March 01, 1993
Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol (1994) 1.99
Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol (1995) 1.63
Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr Biol (2015) 1.58
Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer (2006) 1.08
Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J Assist Reprod Genet (2000) 0.95
Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol (1995) 0.88
Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br J Cancer (2000) 0.88
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes. Am J Pathol (2000) 0.86
Effects of controlled ovarian hyperstimulation on oocyte quality in terms of the incidence of apoptotic granulosa cells. J Assist Reprod Genet (2000) 0.85
In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res (2001) 0.85
Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol (1995) 0.84
Spreading the word: non-autonomous effects of apoptosis during development, regeneration and disease. Development (2015) 0.84
Extent of apoptosis in ovarian serous carcinoma: relation to mitotic and proliferative indices, p53 expression, and survival. Mol Pathol (1997) 0.83
In situ end-labelling, light microscopic assessment and ultrastructure of apoptosis in lung carcinoma. J Clin Pathol (1995) 0.81
An apoptosis-driven 'onco-regenerative niche': roles of tumour-associated macrophages and extracellular vesicles. Philos Trans R Soc Lond B Biol Sci (2018) 0.80
Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice. Am J Pathol (1995) 0.79
Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy. J Clin Pathol (2000) 0.79
Abl expression, tumour grade, and apoptosis in chondrosarcoma. Mol Pathol (1999) 0.78
Correlation between apoptosis, proliferation and bcl-2 expression in malignant non-Hodgkin's lymphoma. Clin Mol Pathol (1996) 0.77
Effects of aging on ovarian fecundity in terms of the incidence of apoptotic granulosa cells. J Assist Reprod Genet (2000) 0.77
β-carotene Regulates the Murine Liver Microenvironment of a Metastatic Neuroblastoma. J Cancer Prev (2013) 0.77
Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas. Br J Cancer (1998) 0.76
Modulation of macrophage antitumor potential by apoptotic lymphoma cells. Cell Death Differ (2017) 0.75
Apoptosis and Ki-67 as predictive factors for response to radiation therapy in feline nasal lymphomas. J Vet Med Sci (2016) 0.75
Cell kinetics and cell cycle regulation in lymphomas. J Clin Pathol (2002) 0.75
Expression of Bcl-2 in canine osteosarcoma. Open Vet J (2015) 0.75
Proliferative activity and apoptosis of Langerhans histiocytes in eosinophilic granulomas as evaluated by MIB-1 and TUNEL methods. Clin Mol Pathol (1995) 0.75
Apoptosis, proliferative activity and Bcl-2 expression in Epstein-Barr-virus-positive non-Hodgkin's lymphomas. J Cancer Res Clin Oncol (1997) 0.75
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell (1991) 7.40
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol (1990) 5.90
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A (1991) 5.50
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol (1991) 4.89
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol (1991) 3.82
Updated Kiel classification for lymphomas. Lancet (1988) 3.25
The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol (1990) 3.23
Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif (1991) 2.81
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
Review: assessment of cell proliferation in histological material. J Clin Pathol (1990) 2.41
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (1990) 2.00
Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer (1991) 1.53
The biology of cell death in tumours. Anticancer Res (1985) 1.51
Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet (1990) 1.42
Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res (1990) 1.31
Histological and immunohistological analysis of human lymphomas. Crit Rev Oncol Hematol (1989) 1.22
Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum Pathol (1987) 1.17
Mechanisms of cell death. Arch Toxicol (1991) 1.17
The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro. Clin Immunol Immunopathol (1991) 1.17
T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism. J Exp Med (1991) 1.08
Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. Br J Cancer (1987) 1.05
CD77: an antigen of germinal center B cells entering apoptosis. Eur J Immunol (1991) 1.03
Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell Tissue Kinet (1988) 0.99
Apoptosis: cell death under homeostatic control. Arch Toxicol Suppl (1987) 0.98
DNA flow cytometry of follicular non-Hodgkin's lymphoma. J Clin Pathol (1991) 0.97
Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol (1990) 0.96
Mitosis counts: reproducibility and significance in grading of malignancy. Hum Pathol (1986) 0.96
DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Br J Cancer (1989) 0.94
Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections. Haematologica (1992) 0.93
Reduced apoptotic cell death in follicular lymphoma. J Pathol (1991) 0.91
Development of an apoptosis endonuclease assay. DNA Cell Biol (1991) 0.90
Heterogeneous subgroups among malignant diffuse small B cell lymphomas. A combined nucleometric and immunocytologic study. Lab Invest (1990) 0.81
Image analysis applied to proliferating cells in malignant lymphoma. Cytometry (1988) 0.80
Mitotic activity and survival in advanced non-Hodgkin's lymphoma of unfavourable histology. Eur J Cancer (1990) 0.79
The bcl-2 gene and protein in malignant lymphomas. Bull Cancer (1991) 0.78
Chromosomal assignment of the human homologue encoding SGP-2. Biochem Biophys Res Commun (1990) 0.78
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell (1997) 6.28
Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature (1999) 5.76
Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med (1995) 4.51
Two different subunits of importin cooperate to recognize nuclear localization signals and bind them to the nuclear envelope. Curr Biol (1995) 4.46
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood (2000) 3.99
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol (2001) 3.29
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood (2000) 3.13
Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma: a new quantitative semiology. Arch Dermatol (1999) 2.85
Synovial sarcoma: identification of low and high risk groups. Cancer (1999) 2.82
Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A (1991) 2.82
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67
Importin provides a link between nuclear protein import and U snRNA export. Cell (1996) 2.65
Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med (1997) 2.59
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica (2010) 2.46
A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J (2001) 2.41
ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41
Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40
ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia (2009) 2.28
The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol (1999) 2.22
Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol (1982) 2.22
Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J (2000) 2.18
A tetrameric complex of membrane proteins in the endoplasmic reticulum. Eur J Biochem (1993) 2.04
Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03
Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol (1997) 2.01
Importin 13: a novel mediator of nuclear import and export. EMBO J (2001) 1.98
Malignant cells are collected on circular staplers. Dis Colon Rectum (1992) 1.94
Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol (1989) 1.89
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica (1997) 1.88
Chondroblastoma. A review of seventy cases. J Bone Joint Surg Am (1985) 1.84
PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81
BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76
Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis (1997) 1.74
Autonomic dysfunction in Parkinson's disease. Neurol Sci (2003) 1.69
HIV-associated malignant lymphomas in Kenya (Equatorial Africa) Hum Pathol (1998) 1.66
Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood (1993) 1.63
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol (2009) 1.62
MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J Biol Chem (1999) 1.58
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia (2009) 1.56
The role of positron emission tomography (PET) in the management of lymphoma patients. Ann Oncol (1999) 1.54
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol (1996) 1.54
Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer (1991) 1.53
Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J (1996) 1.53
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol (2008) 1.52
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51
Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients. Ann Oncol (1998) 1.48
Novel genes coding for lithotrophic sulfur oxidation of Paracoccus pantotrophus GB17. J Bacteriol (2000) 1.47
5'-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia. Clin Biochem (1998) 1.47
Mammalian Sec61 is associated with Sec62 and Sec63. J Biol Chem (2000) 1.47
Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol (1989) 1.46
Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J Immunol (2000) 1.44
MR-defecography in obstructed defecation syndrome (ODS): technique, diagnostic criteria and grading. Tech Coloproctol (2013) 1.42
Rhabdomyosarcoma presenting as acute leukemia. J Pediatr Hematol Oncol (1996) 1.42
Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications. Br J Haematol (1994) 1.40
Incorporation of major histocompatibility complex--encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma. Eur J Immunol (1995) 1.40
Late results in patients treated with pi-mesons for bladder cancer. Cancer (1993) 1.39
Tubuloreticular inclusions and viral particles in a case of hairy cell leukemia. Haematologica (1989) 1.39
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia (2007) 1.36
The signal sequence receptor has a second subunit and is part of a translocation complex in the endoplasmic reticulum as probed by bifunctional reagents. J Cell Biol (1990) 1.35
A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur J Immunol (1996) 1.35
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34
The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning and primary structure. Biochem Int (1989) 1.33
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Giant-cell tumor of bone in skeletally immature patients. J Bone Joint Surg Am (1983) 1.31
Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leuk Res (1989) 1.31
Molecular cloning, sequencing and expression in Escherichia coli of the 25-kDa growth-related protein of Ehrlich ascites tumor and its homology to mammalian stress proteins. Eur J Biochem (1989) 1.31
Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol (1996) 1.30
Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosis. Acta Haematol (1985) 1.30
Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology (2003) 1.30
Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol (1994) 1.29
Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res (2000) 1.28
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol (1999) 1.27
Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am (1983) 1.26
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol (1997) 1.26
Histological and immunohistological analysis of human lymphomas. Crit Rev Oncol Hematol (1989) 1.22
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. J Immunol (2000) 1.20
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Ann Oncol (2009) 1.20
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol (1998) 1.20